- Home
- HUDI vs PMN Comparison
HUDI vs PMN Comparison
Compare HUDI & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUDI
- PMN
- Stock Information
- Founded
- HUDI 2018
- PMN 2004
- Country
- HUDI China
- PMN Canada
- Employees
- HUDI N/A
- PMN N/A
- Industry
- HUDI Steel/Iron Ore
- PMN Pharmaceuticals and Biotechnology
- Sector
- HUDI Industrials
- PMN Health Care
- Exchange
- HUDI Nasdaq
- PMN Nasdaq
- Market Cap
- HUDI 19.1M
- PMN 17.0M
- IPO Year
- HUDI 2021
- PMN N/A
- Fundamental
- Price
- HUDI $1.31
- PMN $0.45
- Analyst Decision
- HUDI
- PMN Strong Buy
- Analyst Count
- HUDI 0
- PMN 2
- Target Price
- HUDI N/A
- PMN $4.50
- AVG Volume (30 Days)
- HUDI 14.6K
- PMN 50.5K
- Earning Date
- HUDI 08-05-2025
- PMN 08-07-2025
- Dividend Yield
- HUDI N/A
- PMN N/A
- EPS Growth
- HUDI N/A
- PMN N/A
- EPS
- HUDI 0.01
- PMN N/A
- Revenue
- HUDI $74,270,429.00
- PMN N/A
- Revenue This Year
- HUDI N/A
- PMN N/A
- Revenue Next Year
- HUDI N/A
- PMN N/A
- P/E Ratio
- HUDI $136.03
- PMN N/A
- Revenue Growth
- HUDI N/A
- PMN N/A
- 52 Week Low
- HUDI $1.26
- PMN $0.43
- 52 Week High
- HUDI $3.45
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- HUDI 40.17
- PMN 33.76
- Support Level
- HUDI $1.27
- PMN $0.48
- Resistance Level
- HUDI $1.34
- PMN $0.50
- Average True Range (ATR)
- HUDI 0.05
- PMN 0.03
- MACD
- HUDI -0.01
- PMN -0.00
- Stochastic Oscillator
- HUDI 18.52
- PMN 0.00
About HUDI Huadi International Group Co. Ltd.
Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.